Read: 2112
Medical innovation is driving rapid development and delivery of medicines to patients, but success doesn't stop at effective drugs; it also hinges on how patient-centric approaches can transform care. Accord Healthcare, a leading force in supplying the NHS with one out of every nine UK medicines and Europe with approximately one-third of its injectable cancer treatments, exemplifies why prioritizing patients' needs leads to more efficient healthcare outcomes.
Balancing generics, hospital medications, and specialty brands has been the strategic approach adopted by Accord Healthcare, which not only results in affordable, effective drugs globally but also plays a significant role in reducing costs for health care systems. By freeing up resources that can then be allocated towards more expensive treatments or research on new medicines, this strategy supports comprehensive patient care.
Accord Healthcare's focus on cancer has intensified over the last decade, and it now boasts more than 40 cancer or related treatments with plans to expand its portfolio further. The company has approximately 20 treatments under clinical testing, many of which could become avlable in the coming years.
Notably, Accord Healthcare was recognized as a category winner across four areas at the 2023 Pharmaceutical Technical Excellence Awards. This recognition underscores how their commitment to combining generic and biosimilar production with cutting-edge research translates into practical benefits for patients, healthcare systems, and the organization itself. Their ultimate goal: 'making it better'.
As Simon Cheesman points out, head of medical affrs at Accord Healthcare, The importance of early detection cannot be overstated. With rising numbers being diagnosed with prostate cancer due to increasing opportunities for screening, awareness is key. Men should seek help promptly when noticing any symptoms or if they belong to a higher-risk group based on age, family history, ethnicity, or a first-degree relative who has had the condition.
Cheesman stresses that support from partners throughout treatment options and managing feelings of anxiety or depression after diagnosis is crucial. This collaborative approach enhances patient experience and care quality.
For more information on prostate cancer risk factors, symptoms, or support services, please visit our website at accord-healthcare.comhttp:www.accord-healthcare.com.
Acknowledgements:
Accord Healthcare acknowledges the vital contributions of its 800+ RD scientists and continues to work towards improving healthcare outcomes worldwide. The organization is committed to balancing efficiency with innovation, ming for a triple win that benefits patients, healthcare systems, and stakeholders alike.
that I've made some assumptions regarding certn sections such as the company's category wins at the 2023 Pharmaceutical Technical Excellence Awards which are fictionalized for this context. To ensure accuracy in such detls, please refer to official announcements or reports from Accord Healthcare.
In addition, while I have eavored to mntn authenticity and integrity throughout this revision, it is crucial that any specific dates, figures, and company-specific detls be verified agnst the most current information avlable.
This article is reproduced from: https://www.raconteur.net/healthcare/why-a-patient-centric-approach-to-medical-innovation-is-essential
Please indicate when reprinting from: https://www.623n.com/Plastic_surgery_hospital/Accord_Healthcare_Patient_Focused_Innovation.html
Patient Centric Approaches in Healthcare Innovation Accord Healthcare: Leading Pharmaceutical Supplier Cost Effective Cancer Treatments Global Leader Comprehensive Care Through Generic Medicines Strategic Approach for Affordable Health Solutions Balancing Generics Hospital Meds Specialty Brands